Neurosona
PrivateLast Round
M&A
May 3, 2024
Est. Valuation
$6.04M
Total Funding Raised
$1.69M
Company Overview
Neurosona operates in Healthcare & Life Sciences and is based in Seoul. Its latest recorded funding round was a Corporate Funding round in October 2021.
Neurosona is a medical device company that develops low-intensity focused ultrasound (LIFU) neuromodulation systems for the treatment of brain diseases such as Alzheimer's and major depressive disorder.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical Imaging, Clinical Trials, Mental Health
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurosona Comparables
Compare Neurosona with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| SPIRE Therapeutics, Inc. | 82% | |
| Brain Sonix Corporation | 81% | |
| Deepson Bio | 81% |
For institutional investors. Book with your work email.
Neurosona Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| M&A | May 3, 2024 | ||||
| Corporate Funding | Oct 19, 2021 |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- May 12, 2026
Monthly visitors increased 39% MoM, reaching 4.8K.
- Apr 19, 2026
Monthly visitors grew 84% MoM, reaching 3.4K.
For institutional investors. Book with your work email.
Neurosona Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurosona's valuation, stock price, and market status.
Is Neurosona a public or private company?
Neurosona is a private company.
What is the current stock price of Neurosona?
Neurosona is a private company, so its shares have no public market price. Caplight tracks Neurosona's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurosona worth (valuation)?
Neurosona's valuation is estimated at $6.0M based on funding round data.
Can I buy Neurosona stock?
Neurosona shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurosona's last funding round?
Neurosona's most recent funding round was M&A on May 3, 2024.
Who are the main investors in Neurosona?
Investor information for Neurosona is not publicly disclosed.
Will Neurosona IPO soon?
No public IPO plans have been announced for Neurosona.
How can I track Neurosona secondary market activity?
Caplight tracks bids, offers, and trades in Neurosona's shares on secondary markets.